Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1.

Huang Y, Liu J, Fan L, Wang F, Yu H, Wei W, Sun G.

Onco Targets Ther. 2016 Mar 17;9:1623-33. doi: 10.2147/OTT.S96902.

2.

Molecular biology of gynecological cancer.

Sonoda K.

Oncol Lett. 2016 Jan;11(1):16-22.

3.

Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.

Beach JA, Aspuria PJ, Cheon DJ, Lawrenson K, Agadjanian H, Walsh CS, Karlan BY, Orsulic S.

Oncotarget. 2016 Jan 26;7(4):4167-82. doi: 10.18632/oncotarget.6703.

4.

Genetic instability in the tumor microenvironment: a new look at an old neighbor.

Palumbo A Jr, Da Costa Nde O, Bonamino MH, Pinto LF, Nasciutti LE.

Mol Cancer. 2015 Jul 31;14:145. doi: 10.1186/s12943-015-0409-y. Review.

5.

Enhanced NK cell adoptive antitumor effects against breast cancer in vitro via blockade of the transforming growth factor-β signaling pathway.

Zhao Y, Hu J, Li R, Song J, Kang Y, Liu S, Zhang D.

Onco Targets Ther. 2015 Jun 22;8:1553-9. doi: 10.2147/OTT.S82616.

6.

Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.

Parvani JG, Davuluri G, Wendt MK, Espinosa C, Tian M, Danielpour D, Sossey-Alaoui K, Schiemann WP.

Neoplasia. 2015 Mar;17(3):317-28. doi: 10.1016/j.neo.2015.02.003.

7.

TGF-β Suppresses COX-2 Expression by Tristetraprolin-Mediated RNA Destabilization in A549 Human Lung Cancer Cells.

Kang S, Min A, Im SA, Song SH, Kim SG, Kim HA, Kim HJ, Oh DY, Jong HS, Kim TY, Bang YJ.

Cancer Res Treat. 2015 Jan;47(1):101-9. doi: 10.4143/crt.2013.192.

8.

Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition.

Hamabe A, Konno M, Tanuma N, Shima H, Tsunekuni K, Kawamoto K, Nishida N, Koseki J, Mimori K, Gotoh N, Yamamoto H, Doki Y, Mori M, Ishii H.

Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15526-31. doi: 10.1073/pnas.1407717111.

9.

Silencing DACH1 promotes esophageal cancer growth by inhibiting TGF-β signaling.

Wu L, Herman JG, Brock MV, Wu K, Mao G, Yan W, Nie Y, Liang H, Zhan Q, Li W, Guo M.

PLoS One. 2014 Apr 17;9(4):e95509. doi: 10.1371/journal.pone.0095509.

10.

TGFβ-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cells.

Suresh Babu S, Valdez Y, Xu A, O'Byrne AM, Calvo F, Lei V, Conway EM.

BMC Cancer. 2014 Feb 20;14:113. doi: 10.1186/1471-2407-14-113.

11.

Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.

Javle M, Li Y, Tan D, Dong X, Chang P, Kar S, Li D.

PLoS One. 2014 Jan 20;9(1):e85942. doi: 10.1371/journal.pone.0085942.

12.

Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients.

Stevenson JP, Kindler HL, Papasavvas E, Sun J, Jacobs-Small M, Hull J, Schwed D, Ranganathan A, Newick K, Heitjan DF, Langer CJ, McPherson JM, Montaner LJ, Albelda SM.

Oncoimmunology. 2013 Aug 1;2(8):e26218.

13.

The many faces of C/EBPδ and their relevance for inflammation and cancer.

Balamurugan K, Sterneck E.

Int J Biol Sci. 2013 Sep 20;9(9):917-33. doi: 10.7150/ijbs.7224. Review.

14.

Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.

Yan W, Wu K, Herman JG, Brock MV, Fuks F, Yang L, Zhu H, Li Y, Yang Y, Guo M.

Epigenetics. 2013 Dec;8(12):1373-83. doi: 10.4161/epi.26781.

15.

Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer.

Gibbons AV, Lin JE, Kim GW, Marszalowicz GP, Li P, Stoecker BA, Blomain ES, Rattan S, Snook AE, Schulz S, Waldman SA.

Cancer Res. 2013 Nov 15;73(22):6654-66. doi: 10.1158/0008-5472.CAN-13-0887.

16.

TCTEX1D4, a novel protein phosphatase 1 interactor: connecting the phosphatase to the microtubule network.

Korrodi-Gregório L, Vieira SI, Esteves SL, Silva JV, Freitas MJ, Brauns AK, Luers G, Abrantes J, Esteves PJ, da Cruz E Silva OA, Fardilha M, da Cruz E Silva EF.

Biol Open. 2013 Mar 8;2(5):453-65. doi: 10.1242/bio.20131065.

17.

The relevance of the TGF-β Paradox to EMT-MET programs.

Morrison CD, Parvani JG, Schiemann WP.

Cancer Lett. 2013 Nov 28;341(1):30-40. doi: 10.1016/j.canlet.2013.02.048. Review.

18.

Digitoxin and its analogs as novel cancer therapeutics.

Elbaz HA, Stueckle TA, Tse W, Rojanasakul Y, Dinu CZ.

Exp Hematol Oncol. 2012 Apr 5;1(1):4. doi: 10.1186/2162-3619-1-4.

19.

The transcription factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism.

Zheng X, Vittar NB, Gai X, Fernandez-Barrena MG, Moser CD, Hu C, Almada LL, McCleary-Wheeler AL, Elsawa SF, Vrabel AM, Shire AM, Comba A, Thorgeirsson SS, Kim Y, Liu Q, Fernandez-Zapico ME, Roberts LR.

PLoS One. 2012;7(11):e49581. doi: 10.1371/journal.pone.0049581.

20.

Novel genes and pathways modulated by syndecan-1: implications for the proliferation and cell-cycle regulation of malignant mesothelioma cells.

Szatmári T, Mundt F, Heidari-Hamedani G, Zong F, Ferolla E, Alexeyenko A, Hjerpe A, Dobra K.

PLoS One. 2012;7(10):e48091. doi: 10.1371/journal.pone.0048091.

Items per page

Supplemental Content

Support Center